AI-Based Multimodal Integration for Tumor Microenvironment Analysis and Response Prediction in HCC Treated With TACE Plus Immunotherapy and Targeted Therapy (CHANCE2601)
NCT07584317
·
clinicaltrials.gov ↗
NOT_YET_RECRUITING
Status
1170
Enrollment
OTHER
Sponsor class
Conditions
Hepatocellular Carcinoma
Interventions
OTHER:
Artificial Intelligence
Sponsor
Gao-jun Teng